E Kr̆epela
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
Papers in ⓘ
- Oncology 35
- Peptidase Inhibition and Analysis 27
- Lung Cancer Research Studies 4
-
- Cell death mechanisms and regulation 6
- Signaling Pathways in Disease 4
- Co-authors
- Aleksi Šedo (17 shared papers)Pavel Fiala (6 shared papers)A Kubík (3 shared papers)Petr Zatloukal (4 shared papers)Bonnie F. Sloane (2 shared papers)Jurij Rozhin (2 shared papers)Kamiar Moin (1 shared paper)E Kasafírek (8 shared papers)
- Journals
- Biological Chemistry (3 papers)International Journal of Oncology (3 papers)Lung Cancer (3 papers)Journal of Cancer Research and Clinical Oncology (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- CzechiaIndiaUnited States
In The Last Decade
E Kr̆epela
46 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Oncology 710
- Cancer Research 384
- Pulmonary and Respiratory Medicine 424
- Immunology and Allergy 68
- Cellular and Molecular Neuroscience 177
Countries citing papers authored by E Kr̆epela
This map shows the geographic impact of E Kr̆epela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Kr̆epela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Kr̆epela more than expected).
Fields of papers citing papers by E Kr̆epela
This network shows the impact of papers produced by E Kr̆epela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Kr̆epela. The network helps show where E Kr̆epela may publish in the future.
Co-authors
The 25 scholars most cited alongside E Kr̆epela, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 329 | |
| 2 | 1990 | 163 | |
| 3 | 2009 | 78 | |
| 4 | 2016 | 65 | |
| 5 | 2007 | 63 | |
| 6 | 2004 | 52 | |
| 7 | 2004 | 51 | |
| 8 | 2004 | 49 | |
| 9 | Cysteine proteinases in tumor cell growth and apoptosis. | 2001 | 46 |
| 10 | Increased cathepsin B activity in human lung tumors. | 1990 | 45 |
| 11 | 1991 | 33 | |
| 12 | 2012 | 32 | |
| 13 | 1987 | 32 | |
| 14 | Cathepsin B in human breast tumor tissue and cancer cells. | 1989 | 26 |
| 15 | 2017 | 23 | |
| 16 | Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. | 1998 | 22 |
| 17 | 2012 | 22 | |
| 18 | 2005 | 21 | |
| 19 | 1989 | 20 | |
| 20 | 2008 | 19 |
About E Kr̆epela
E Kr̆epela is a scholar working on Oncology, Molecular Biology, Cancer Research, Cellular and Molecular Neuroscience and Epidemiology, having authored 46 papers that have together received 1.5k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (27 papers), Protease and Inhibitor Mechanisms (15 papers), Neuropeptides and Animal Physiology (9 papers), Cell death mechanisms and regulation (6 papers), Neuroendocrine Tumor Research Advances (6 papers), Bone and Dental Protein Studies (5 papers), Signaling Pathways in Disease (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Oncology (710 citations), Cancer Research (384 citations), Pulmonary and Respiratory Medicine (424 citations), Immunology and Allergy (68 citations) and Cellular and Molecular Neuroscience (177 citations). E Kr̆epela has collaborated with scholars based in Czechia, India and United States. Frequent co-authors include Aleksi Šedo, Pavel Fiala, A Kubík, Petr Zatloukal, Bonnie F. Sloane, Jurij Rozhin, Kamiar Moin, E Kasafírek, Libor Havel and Luboš Petruželka. Their work appears in journals such as Biological Chemistry, International Journal of Oncology, Lung Cancer, Journal of Cancer Research and Clinical Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.